The new direct-to-employer model supports rising demand for FDA-approved obesity medications.Eli Lilly and Novo Nordisk are collaborating with Waltz Health to launch direct-to-employer access for obesity management medications. Waltz Health gave no information on the prices of GLP-1 drugs available to employees in the plan.It said the plan offers employers transparent pricing and a new […]
